Ingredient change for Japan market

Chemicals company, BASF, has reformulated an active delivery product, enabling it to adhere to the regulations of Japanese “quasi drugs”, opening up potential for formulators to target the Japanese skin whitening market.

 According to BASF, the original product, Cytovector, intelligently penetrates the cell membrane, allowing it to aid the delivery of active ingredients, such as anti-wrinkle creams and skin whitening products. The new formulation, Cytovector QD, has had one of the ingredients, quaternised soy protein, removed and replaced with another ingredient with similar efficacy, but which is listed with the Japanese Standard of Quasi-Drug Ingredients.

Latest Issues

Connex-C Asia 2025

Lee Kong Chian School of Medicine - Ong Tiong Tat and Irene Tan Liang Kheng Auditorium 11 Mandalay Road, Level 4, Singapore 308232
31 July - 1 August 2025

IFSCC Congress 2025

Palais des Festivals, Cannes
15th - 18th September 2025